Nasrin Esnaashari, NP
Nurse Practitioner · Los Angeles, CANPI 1831389477
Payments from drug & device makers
Across 71 payments — averaging $128.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$3K
- MDD US Operations, LLC$2K
- Medtronic$750
- AbbVie$302
- Eisai Inc.$122
- plus $189 from 3 others
What the payments were for
- Consulting fees$6007%
- Speaking & faculty fees$1,17013%
- Travel & lodging$3,85142%
- Food & beverage$3,43838%
- Education$721%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $3,048 |
| Abbott | 23 | $2,826 |
| MDD US Operations, LLC | 16 | $1,893 |
| Medtronic | 9 | $750 |
| AbbVie(2 entities) | 4 | $302 |
| Eisai Inc. | 1 | $122 |
| Neurocrine Biosciences, Inc. | 1 | $100 |
| Acadia Pharmaceuticals Inc | 1 | $59 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$1,639
- VERCISE$914
- Infinity DBS Pulse Generators$762
- GOCOVRI$614
- GENERAL DBS$315
- PERCEPT PC BRAINSENSE$174
- QULIPTA$124
- UBRELVY$124
- Leqembi$122
- Duopa$122
How this compares
$9,130 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 37 | $23,491 |
| Rasagiline Mesylate | 14 | $2,870 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 50 | $1,872 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 33 | $755 |
| Escitalopram Oxalate | 21 | $412 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Los Angeles
- Kristin HorwoodLos Angeles$99K
- Yunying ChenLos Angeles$80K
- Lauren BristowLos Angeles$46K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.